A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

Dahlöf, C., Jones, M., Davis, K., Loftus, J., Salonen, R. (2004). A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine. https://doi.org/10.1007/s10194-004-0079-4

Dahlöf, Carl, et al.. "A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine". CrossRef, 2004. doi:10.1007/s10194-004-0079-4.

@article{dahlöf2004, author = {Carl Dahlöf and Martin Jones and Kim Davis and Jane Loftus and Reijo Salonen}, title = {A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine}, year = {2004}, journal = {CrossRef}, doi = {10.1007/s10194-004-0079-4}, url = {https://doi.org/10.1007/s10194-004-0079-4}, }

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

Penulis (5)

Format Sitasi

Akses Cepat